{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:56:22Z","timestamp":1775253382816,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s10875-018-0481-3","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T03:12:51Z","timestamp":1518837171000},"page":"214-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Investigating the Effectiveness, Acceptability and Impact on Healthcare Usage of Providing a Cognitive-Behavioural Based Psychological Therapy Service for Patients with Primary Antibody Deficiency"],"prefix":"10.1007","volume":"38","author":[{"given":"Mari","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Symes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarita","family":"Workman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Stauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. David","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"481_CR1","volume-title":"Long-term conditions and mental health: the cost of comorbidities","author":"C Naylor","year":"2012","unstructured":"Naylor C, Parsonage M, McDaid D, Knapp M, Fossey MY, Galea A. Long-term conditions and mental health: the cost of comorbidities. London: The King\u2019s Fund and Centre for Mental Health; 2012."},{"key":"481_CR2","unstructured":"National Institute of Clinical Excellence. Depression: treatment and management of depression in adults, including adults with a chronic physical health problem. 2009."},{"key":"481_CR3","volume-title":"Long-term conditions positive practice guide","author":"Department of Health","year":"2008","unstructured":"Department of Health. Long-term conditions positive practice guide. London: Department of Health; 2008."},{"key":"481_CR4","volume-title":"High quality care for all","author":"Department of Health","year":"2008","unstructured":"Department of Health. High quality care for all. London: Department of Health; 2008."},{"key":"481_CR5","volume-title":"No health without mental health: a cross-government mental health outcomes strategy for people of all ages","author":"Department of Health","year":"2011","unstructured":"Department of Health. No health without mental health: a cross-government mental health outcomes strategy for people of all ages. London: Department of Health; 2011."},{"key":"481_CR6","unstructured":"National Institute of Clinical Excellence. Chronic fatigue syndrome\/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of chronic fatigue syndrome\/myalgic encephalomyelitis (or encephalopathy) in adults and children. 2007."},{"issue":"9259","key":"481_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0140-6736(00)04198-2","volume":"357","author":"JB Prins","year":"2001","unstructured":"Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet. 2001;357(9259):841\u20137. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(00)04198-2\n                    \n                  .","journal-title":"Lancet"},{"key":"481_CR8","unstructured":"British Pain Society. Recommended guidelines for pain management programmes for adults. 2007."},{"key":"481_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.7326\/0003-4819-129-8-199810150-00005","volume":"129","author":"PJ Lustman","year":"1997","unstructured":"Lustman PJ, Griffith LS, Freedland KE, Kissel SS, Clouse RE. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann Intern Med. 1997;129:613\u201321.","journal-title":"Ann Intern Med"},{"issue":"4","key":"481_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1017\/S0033291701003890","volume":"31","author":"ME Kunik","year":"2001","unstructured":"Kunik ME, Braun U, Stanley MA, Wristers K, Molinari V, Stoebner D, et al. One session cognitive behavioural therapy for elderly patients with chronic obstructive pulmonary disease. Psychol Med. 2001;31(4):717\u201323.","journal-title":"Psychol Med"},{"key":"481_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cei.12172","volume":"175","author":"DM Edgar","year":"2013","unstructured":"Edgar DM, Buckland M, Guzman D, et al. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years\u2019 activity 2008-2012. Clin Exp Immunol. 2013;175:68\u201378.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"481_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.iac.2008.01.001","volume":"28","author":"PF Yong","year":"2008","unstructured":"Yong PF, Tarzi M, Chua I, Grimbacher B, Chee R. Common variable immunodeficiency: an update on etiology and management. Immunol Allergy Clin N Am. 2008;28(2):367\u201386. \n                    https:\/\/doi.org\/10.1016\/j.iac.2008.01.001\n                    \n                  .","journal-title":"Immunol Allergy Clin N Am"},{"key":"481_CR13","first-page":"595","volume":"6","author":"P Wood","year":"2008","unstructured":"Wood P. Primary antibody deficiencies: recognition, clinical diagnosis and referral of patients. Clin Med. 2008;6:595\u20139.","journal-title":"Clin Med"},{"key":"481_CR14","unstructured":"Booker K, Bansal A, Haeney M, Bansal J, Vieira A. Identifying risk for sub-optimal health-related quality of life and adjustment to illness in adults with primary antibody deficiency syndrome (PADS): summary report for the PiA. 2007."},{"key":"481_CR15","unstructured":"Edwards L, O\u2019Donovan A, Petrak J. An investigation of coping and psychosocial functioning in persons with common variable immunodeficiency (CVID). P.I.A. Summary Report. 2003."},{"issue":"3","key":"481_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3349\/ymj.2012.53.3.603","volume":"53","author":"I Quinti","year":"2012","unstructured":"Quinti I, Di Pietro C, Martini H, Pesce AM, Lombardi F, Baumghartner M, et al. Health related quality of life in common variable immunodeficiency. Yonsei Med J. 2012;53(3):603\u201310. \n                    https:\/\/doi.org\/10.3349\/ymj.2012.53.3.603\n                    \n                  .","journal-title":"Yonsei Med J"},{"key":"481_CR17","unstructured":"PID UK. Patients\u2019 experience survey of primary immunodeficiency disorders (PID Services). 2016."},{"key":"481_CR18","unstructured":"Care Quality Commission. From the pond into the sea: children\u2019s transition into adult health services. 2014."},{"key":"481_CR19","unstructured":"Department of Health. Report of the Children and Young People\u2019s Health Outcomes Forum (CYPHOF). 2012."},{"key":"481_CR20","unstructured":"Booker K (personal communication, April 2014). Primary Immunodeficiency Quality of Life Index."},{"issue":"2","key":"481_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) Measurement System. J Pain Symptom Manag. 1997;13(2):63\u201374. \n                    https:\/\/doi.org\/10.1016\/S0885-3924(96)00274-6\n                    \n                  .","journal-title":"J Pain Symptom Manag"},{"key":"481_CR22","unstructured":"FACIT.org (personal communication, April 2011). The Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Scale: summary of development and validation. June 27, 2007 Update."},{"issue":"6","key":"481_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370. \n                    https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x\n                    \n                  .","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"481_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7525-1-29","volume":"1","author":"RP Snaith","year":"2003","unstructured":"Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1(1):29. \n                    https:\/\/doi.org\/10.1186\/1477-7525-1-29\n                    \n                  .","journal-title":"Health Qual Life Outcomes"},{"key":"481_CR25","unstructured":"Sheridan, C. L. (personal communication, 12 May 2011). Introduction to the inventory of health status."},{"issue":"4","key":"481_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385\u201396. \n                    https:\/\/doi.org\/10.2307\/2136404\n                    \n                  .","journal-title":"J Health Soc Behav"},{"key":"481_CR27","unstructured":"FACIT.org (personal communication, April 2011). The Functional Assessment of Chronic Illness Therapy - Treatment Satisfaction - General (FACIT-TS-G) Scale: reliability and validity report."},{"issue":"6","key":"481_CR28","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1037\/ccp0000044","volume":"83","author":"E Fernandez","year":"2015","unstructured":"Fernandez E, Salem D, Swift JK, Ramtahal N. Meta-analysis of dropout from cognitive behavioral therapy: magnitude, timing, and moderators. J Consult Clin Psychol. 2015;83(6):1108\u201322. \n                    https:\/\/doi.org\/10.1037\/ccp0000044\n                    \n                  .","journal-title":"J Consult Clin Psychol"},{"key":"481_CR29","unstructured":"Naylor C, Das P, Ross S, Honeyman M, Thompson J, Gilburt H. Bringing together physical and mental health: a new frontier for integrated care. The Kings Fund. 2016."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-018-0481-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0481-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T03:07:09Z","timestamp":1550372829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-018-0481-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s10875-018-0481-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"26 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The project was funded by the Primary Immunodeficiency Association, the Royal Free Special Trustees and the Royal Free Charity. Mari Campbell has received financial support to attend symposia from CSL, Grifols, BPL and Biotest, an honorarium from Shire. Andrew Symes has received payments from SCL, Octapharma and Grifols. Sarita Workman has received honorariums from Biotest and LFB, sponsorship from SCL, Octapharma, Grifols, Biotest, BPL and FLB for attendance at Educational Meetings, and an education grant from CSL Behring. Hans Stauss is an advisor and shareholder of Cell Medica and recipient of funding from this biotech company. There are no further conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}